Dr Azeem Saleem is a Reader at the University of Hull and a Honorary Consultant in Clinical Oncology at the Queen's Centre, Castle Hill Hospital.
Dr Azeem Saleem is a Clinical Oncologist by training with a research background in molecular imaging with wide experience in industry and academia. He obtained his medical qualification (MB BS) in 1988 from Madras University, India and did his research fellowship at the Medical Research Council (MRC) Cyclotron Unit, Hammersmith Hospital, London between 1997 and 2000, evaluating the utility of positron emission tomography (PET) in anti-cancer drug development to obtain his PhD.
He then went on to complete his specialist training in Clinical Oncology at Merseyside. He was appointed as a Senior Clinical Research Fellow at the University of Manchester Wolfson Molecular Imaging Centre and an Honorary Consultant in Clinical Oncology at the Christie Hospital in 2005. In 2009, he joined the GlaxoSmithKline Clinical Imaging Centre at the Hammersmith Hospital to lead the oncology imaging programme and as an honorary senior clinical lecturer at Imperial College. From 2011 to 2017, he headed oncology and respiratory medicine applications at Imanova Centre for Imaging Sciences, an Imperial College, University College London, Kings College London and MRC joint venture which aimed to provide imaging expertise to academia and commercial organisations. From 2018, he was the UK Head of Oncology at Invicro, a Konica Minolta Company. He joined the University of Hull in December 2019.
Dr Saleem's area of research is translational molecular (PET and MR) imaging studies in oncology. First in human clinical studies with novel PET radiotracers and novel drug assets. Radiotherapy and clinical oncology studies.
Dr Azeem Saleem's publications are available on the University of Hull Research Repository.